Beta-blockers should remain as first-line therapy in the management of hypertension.
Krum
H
H
Department of Epidemiology & Preventive Medicine, Monash Centre of Cardiovascular Research & Education in Therapeutics, Monash University, Melbourne, Vic., Australia. henry.krum@med.monash.edu.au
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents